Latest Breaking News On - Apirx pharmaceuticals - Page 1 : comparemela.com

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report .

South australiaUnited statesNew zealandJoel lathamRedomiciling incannexPeter widdowsApril incannexDrug administrationEarly phase clinical researchIncannex healthcareClinical researchIv clinical researchQuest pharmaceutical servicesClarion clinics group pty ltdHuman research ethics committeeClarion clinics group

These tech and pharma stocks are looking to M&A to drive growth in global markets

These tech and pharma stocks are looking to M&A to drive growth in global markets
stockhead.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockhead.com.au Daily Mail and Mail on Sunday newspapers.

United statesNew zealandSan diegoKuala lumpurUnited kingdomCraig scroggieDedicaid gmbWarren buffett berkshire hathawaySanta barbaraSteve osborneGoldman sachsEpilepsy specialist clinical advisory serviceI am billy foundationSpirit aerosystemsMclane companyRoolife group

Date: April 14, 2023 Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K

Date: April 14, 2023 Public Announcement Incannex Appoints QPS to Advance. | April 14, 2023

United statesJoel lathamMarcus meinardiApirx pharmaceuticalsEuropean union medicines agencyIncannex healthcare ltd nasdaqCentre for disease controlEdison groupAustralian stock exchangeIv clinical researchEarly phase clinical researchIncannex healthcareMarket researchQuest pharmaceutical servicesIncannex healthcare limitedDrug administration

Incannex Appoints QPS to Advance CannQuit-N™ (Nicotine), CannQuit-O™ (Opioid) and Renecann™ Products in the USA and EU

Incannex Appoints QPS to Advance CannQuit-N™ (Nicotine), CannQuit-O™ (Opioid) and Renecann™ Products in the USA and EU
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJoel lathamLimitedmr joel lathammanagingMarcus meinardiCentre for disease controlIncannex healthcareEarly phase clinical researchIncannex healthcare ltd nasdaqQuest pharmaceutical servicesUnited states alyssa factor edison groupDrug administrationApirx pharmaceuticalsIv clinical researchAustralian stock exchangeEuropean union medicines agencyMarket research

Incannex Appoints QPS to Advance CannQuit-N (Nicotine), CannQuit-O (Opioid) and Renecann Products in the USA and EU

14.04.2023 - MELBOURNE, Australia, April 14, 2023 (GLOBE NEWSWIRE) - Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted . Seite 1

Joel lathamEuropean union medicines agencyApirx pharmaceuticalsDrug administrationEuropean unionEuropean medicines agencyManaging director